All news How can Dr Kelly Starrett’s mobility strategies improve your daily life?By MichaelJanuary 16, 2025 All news Will we see approved Alzheimer’s blood tests in 2025?By MichaelJanuary 16, 2025 Roche scientist discusses recent progress in blo All news Ultrahuman and InsideTracker join forces on preventive health in the USBy MichaelJanuary 16, 2025 Healthtech companies combine blood testing analy All news Bioptimus adds $41m to build ‘the GPT of biology’By MichaelJanuary 15, 2025 French AI startup expects to launch first multi- All news UK Biobank announces largest-ever proteomics studyBy MichaelJanuary 15, 2025 Comprehensive study aims to analyze 5,400 protei All news C2N Diagnostics partners with Michael J. Fox FoundationBy MichaelJanuary 14, 2025 C2N Diagnostics announced a partnership with the All news Ashvattha lands funding to advance inflammation-targeting nanomedicinesBy MichaelJanuary 14, 2025 Clinical stage biotech engaged in ongoing trials All news ‘I see huge scope in longevity medicine’By MichaelJanuary 14, 2025 BioAro’s Anmol Kapoor on Dubai as a centre for All news Tune dials-in $175m to advance epigenetic editing therapiesBy MichaelJanuary 13, 2025 Hevolution joins investors backing biotech that All news FLF:SG ‘Longevity really resides in prevention’By MichaelJanuary 13, 2025 Yuta Lee on the future of stem cell therapies in Previous 1 … 140 141 142 143 144 … 451 Next
All news Ultrahuman and InsideTracker join forces on preventive health in the USBy MichaelJanuary 16, 2025 Healthtech companies combine blood testing analy
All news Bioptimus adds $41m to build ‘the GPT of biology’By MichaelJanuary 15, 2025 French AI startup expects to launch first multi-
All news UK Biobank announces largest-ever proteomics studyBy MichaelJanuary 15, 2025 Comprehensive study aims to analyze 5,400 protei
All news C2N Diagnostics partners with Michael J. Fox FoundationBy MichaelJanuary 14, 2025 C2N Diagnostics announced a partnership with the
All news Ashvattha lands funding to advance inflammation-targeting nanomedicinesBy MichaelJanuary 14, 2025 Clinical stage biotech engaged in ongoing trials
All news ‘I see huge scope in longevity medicine’By MichaelJanuary 14, 2025 BioAro’s Anmol Kapoor on Dubai as a centre for
All news Tune dials-in $175m to advance epigenetic editing therapiesBy MichaelJanuary 13, 2025 Hevolution joins investors backing biotech that
All news FLF:SG ‘Longevity really resides in prevention’By MichaelJanuary 13, 2025 Yuta Lee on the future of stem cell therapies in
